BNTX
BNTX
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
0
$0
Insider Sales
3
$19.34M
Total Volume
$19.34M
3 transactions
Net Activity
$19.34M
Net selling
Sentiment Rating
Heavy DistributionCEO Conviction Index
Liquidating / Profit Taking
Key Drivers
- •Heavy distribution: sales represent 100% of total transaction value.
- •CEO selling activity detected. Often driven by option expiration or diversification plans.
- •Significant liquidation: total sale value exceeds $10M.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Sahin Ugur
CEO, 10%
$19.34M total
Quick Actions
BNTX has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%.
Over the last 90 days, corporate insiders at BNTX (BNTX) engaged in a total of 3 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 3 were sales. The total volume of insider trading reached $19.34M.
The net insider activity for BNTX shows a net selling bias of $19.34M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Sahin Ugur (CEO, 10%), who traded 69.0K shares valued at $6.84M on Sep 23, 2026.
BioNTech (BNTX) Stock Looks Fully Valued As Sales Face Pressure
BNTX Stock Price and Chart — NASDAQ:BNTX
BioNTech May Be the Next Moderna. Even if it Isn’t, the Stock Is a Buy.
BioNTech: Priority Review Voucher Purchase Hints At Much Needed Approval Shot
Another BioNTech Cancer Vaccine Just Hit a Major Setback. Is BNTX Stock Still a Buy?
Trading the Move, Not the Narrative: (BNTX) Edition
FAQs About BNTX Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for BNTX.